Fixed Drug Eruption to Trimethoprim-Sulfamethoxazole and Doxycycline

Fixed drug eruption (FDE) is a common cutaneous drug eruption. We are the first to report a case of polysensitive FDE to both trimethoprim-sulfamethoxazole (TMP-SMX) and doxycycline. Diagnosis of FDE is largely clinical, and it is important to establish a good medication history to identify the caus...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Clara Y, Wong, Noelle, Burns, Ariel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121196/
https://www.ncbi.nlm.nih.gov/pubmed/34007755
http://dx.doi.org/10.7759/cureus.14502
_version_ 1783692277463384064
author Long, Clara Y
Wong, Noelle
Burns, Ariel
author_facet Long, Clara Y
Wong, Noelle
Burns, Ariel
author_sort Long, Clara Y
collection PubMed
description Fixed drug eruption (FDE) is a common cutaneous drug eruption. We are the first to report a case of polysensitive FDE to both trimethoprim-sulfamethoxazole (TMP-SMX) and doxycycline. Diagnosis of FDE is largely clinical, and it is important to establish a good medication history to identify the causative agent. Treatment depends on avoidance of the implicated drug.
format Online
Article
Text
id pubmed-8121196
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-81211962021-05-17 Fixed Drug Eruption to Trimethoprim-Sulfamethoxazole and Doxycycline Long, Clara Y Wong, Noelle Burns, Ariel Cureus Dermatology Fixed drug eruption (FDE) is a common cutaneous drug eruption. We are the first to report a case of polysensitive FDE to both trimethoprim-sulfamethoxazole (TMP-SMX) and doxycycline. Diagnosis of FDE is largely clinical, and it is important to establish a good medication history to identify the causative agent. Treatment depends on avoidance of the implicated drug. Cureus 2021-04-15 /pmc/articles/PMC8121196/ /pubmed/34007755 http://dx.doi.org/10.7759/cureus.14502 Text en Copyright © 2021, Long et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Long, Clara Y
Wong, Noelle
Burns, Ariel
Fixed Drug Eruption to Trimethoprim-Sulfamethoxazole and Doxycycline
title Fixed Drug Eruption to Trimethoprim-Sulfamethoxazole and Doxycycline
title_full Fixed Drug Eruption to Trimethoprim-Sulfamethoxazole and Doxycycline
title_fullStr Fixed Drug Eruption to Trimethoprim-Sulfamethoxazole and Doxycycline
title_full_unstemmed Fixed Drug Eruption to Trimethoprim-Sulfamethoxazole and Doxycycline
title_short Fixed Drug Eruption to Trimethoprim-Sulfamethoxazole and Doxycycline
title_sort fixed drug eruption to trimethoprim-sulfamethoxazole and doxycycline
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121196/
https://www.ncbi.nlm.nih.gov/pubmed/34007755
http://dx.doi.org/10.7759/cureus.14502
work_keys_str_mv AT longclaray fixeddrugeruptiontotrimethoprimsulfamethoxazoleanddoxycycline
AT wongnoelle fixeddrugeruptiontotrimethoprimsulfamethoxazoleanddoxycycline
AT burnsariel fixeddrugeruptiontotrimethoprimsulfamethoxazoleanddoxycycline

Ejemplares similares